blokhin-bm 1

1. Antibody-based biological antiviral drugs for the prevention and treatment of acute respiratory viral infections in immunocompromised patients: focus on safety
2. Efficacy and Safety of Ergoferon in Children from 6 Months to 6 Years Old with Acute Respiratory Viral Infections in Contemporary Outpatient Practice: A Multicenter, Double-Blind, Placebo-Controlled Randomized Trial
3. Impact of immunomodulation therapy on the course of acute viral respiratory infections: A meta-analysis of clinical trials assessing the efficacy and safety of ergoferon in the treatment of influenza and other acute respiratory viral infections
1